BioCardia Has Been Granted U.S. Patent Number 12,036,371 Titled "Method of accessing the left atrium with a multi-directional steerable catheter"
Portfolio Pulse from Benzinga Newsdesk
BioCardia has been granted U.S. Patent Number 12,036,371 for a method of accessing the left atrium with a multi-directional steerable catheter.
July 16, 2024 | 7:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioCardia has received a new U.S. patent for a method of accessing the left atrium with a multi-directional steerable catheter, potentially enhancing its product portfolio and market position.
The new patent strengthens BioCardia's intellectual property portfolio, potentially leading to new product developments and competitive advantages in the medical device market. This could positively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100